ArticleFrontiers in oncology2025

Neoadjuvant programmed death ligand-1 with chemotherapy versus chemotherapy alone for limited-stage small-cell lung cancer: a retrospective study.

Zhi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.